Rick Orford
About The Author
LATEST ARTICLES
-
Eli Lilly Stock Could Surge 45% in 2026 as Obesity Drug Sales Explode
Eli Lilly (NYSE: LLY) is entering 2026 with explosive revenue growth, strong momentum in its powerful obesity drug, and multiple Phase 3 catalysts. With guidance pointing toward $83 billion in revenue and analysts targeting major upside, this healthcare giant could still have significant room to run. Stock prices used were the market prices of Feb.…
-
Rigetti Computing’s 1300% Surge Comes With a Catch
Rigetti Computing (NASDAQ: RGTI) has surged more than 1,300%, yet revenue remains tiny and losses are mounting. I break down what the company has actually built, the real financial risks, and what must happen for quantum relevance by 2030. Stock prices used were the market prices of Feb. 9, 2026. The video was published on…
-
Vistra Stock: The AI Power Play Wall Street Is Betting On
Vistra Energy Corp (NYSE: VST) is being revalued as an AI power play, not a traditional utility. I break down the contracts, risks, and execution needed for this stock to justify massive upside from here. Stock prices used were the market prices of Feb. 10, 2026. The video was published on Feb. 16, 2026. On…
-
Amazon’s $200 Billion AI Bet Could Send Shares to $360
Amazon (NASDAQ: AMZN) is making a $200 billion AI gamble that could redefine its future. If AWS, Bedrock, and Anthropic ignite a powerful earnings flywheel, the path to $360 may be realistic. But expectations are sky high. Is this the next AI compounding machine, or a valuation trap in disguise? Stock prices used were the…
-
Archer Aviation Faces a Critical Test as FAA Delays Drag On
Archer Aviation (NYSE: ACHR) is chasing massive upside while navigating FAA delays, heavy losses, and a strategic pivot toward defense revenue. I break down the risks, the runway, and what investors need to see next. Stock prices used were the market prices of Feb. 9, 2026. The video was published on Feb. 15, 2026. On…
-
Rocket Lab’s Neutron Delay: Why Investors Should Pay Attention Now
Rocket Lab (NASDAQ: RKLB) just hit turbulence after a critical Neutron test failure, but the long-term opportunity may be bigger than ever. I break down the delay, revenue risks, analyst price targets, and why this next rocket could redefine the company’s growth trajectory. Stock prices used were the market prices of Feb. 9, 2026. The…
-
Super Micro Faces a Trust Problem Despite AI Boom
Super Micro Computer (NASDAQ: SMCI) is seeing explosive AI demand, yet its stock trades at a discount due to margin pressure and trust concerns. I break down what went wrong, what must improve, and where the upside could come from. Stock prices used were the market prices of Feb. 9, 2026. The video was published…
-
Marvell Technology Faces a Valuation Reality Check
Marvell Technology (NASDAQ: MRVL) is posting record earnings and dominating AI data centers, yet the stock still struggles. I break down valuation, execution risk, and what must go right for upside to continue. Stock prices used were the market prices of Feb. 9, 2026. The video was published on Feb. 14, 2026. On the date…
-
NextEra Energy Could Be the Clean Energy Utility Investors Overlook
NextEra Energy (NYSE: NEE) is not your average utility. With a massive renewable backlog, disciplined dividend growth, and regulated cash flow, this stock may quietly reward patient investors who focus on income and long-term stability. Stock prices used were the market prices of Feb. 6, 2026. The video was published on Feb. 13, 2026. On…
-
SoundHound AI Is Taking a Different Path Than Big Tech
SoundHound AI (NASDAQ: SOUN) is carving out a niche in enterprise voice and agentic AI with white-label solutions for restaurants and businesses. If revenue scales and losses narrow, the upside could be significant. But execution matters, and the margin for error is thin. Stock prices used were the market prices of Feb. 5, 2026. The…